This CLI will create an interactive graph of all the functions and their calls in the TypeScript files you provide. ⚠️ This is a work in progress 🚧 More visualization contributions are welcome.

This is a JavaScript implementation of a graphical calculator, with support for standard algebraic functions in the Cartesian plane. Features include fast, accurate graphing and full mouse zoom and ...

Roll Tide! No that’s more like it. This graphing column, I’ll admit, is a much more interesting read when we’re breaking down ...

Learning embeddings for entities and relations in knowledge graph (KG) have benefited many downstream tasks. In recent years, scoring functions, the crux of KG learning, have been human designed to ...

The Cupertino-based giant finally announced a Calculator app for iPad after around 14 years of the iPad's debut during 2024's ...

Here is a recap of what happened in the search forums today, through the eyes of the Search Engine Roundtable and other search forums on the web. Google won't be broken up, but they will have to share ...

Here are some retro gadgets that you might still have (or can pick up for cheap) that work just as well as they ever did. Both film and digital cameras still have their place in a world dominated by ...

This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...

The daily Sea Ice Index provides a quick look at Arctic-wide changes in sea ice. It provides consistently processed daily ice extent and concentration images and data since 1979. Daily extent images ...

This valuable study introduces a non-perturbative pulse-labeling strategy for yeast nuclear pore complexes (NPCs), employing a nanobody-based approach in order to selectively capture Nup84-containing ...

How Time Flies is a daily feature looking back at Pantagraph archives to revisit what was happening in our community and region. See today in history: ...

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.